Papillomatosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

M7824 in People With Recurrent Respiratory Papillomatosis
Conditions:   Recurrent Respiratory Papillomatosis;   Respiratory Papillomatosis;   Laryngeal Papilloma, Recurrent;   Human Papilloma Virus Intervention:   Drug: M7824 Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2018 Category: Research Source Type: clinical trials